Get the Stockscreener App
2.91
0.68%
-0.02
Bionano Genomics Inc stock is traded at $2.91, with a volume of 72,926.
It is down -0.68% in the last 24 hours and down -12.35% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$2.93
Open:
$2.93
24h Volume:
72,926
Relative Volume:
0.73
Market Cap:
$9.79M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.1637
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-1.36%
1M Performance:
-12.35%
6M Performance:
-50.17%
1Y Performance:
-87.95%
1-Day Range:
$2.87
$2.9568
1-Week Range:
$2.87
$3.0902
52-Week Range:
$2.68
$37.09
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
2.91 | 10.09M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
What data driven models say about Bionano Genomics Inc.’s futureWeekly Price Target Forecast and Alerts - Newser
Bionano Genomics Inc. Stock Performance After Earnings: Historical InsightsWeekly Stock Picks with Trend Confidence - Newser
What makes Bionano Genomics Inc. stock price move sharplyShort-Term Bounce Forecast for Oversold Stocks - Newser
Bionano Announces Publication Showing Utility of Optical Genome - GuruFocus
Bionano Announces Publication Showing Utility of Optical - GlobeNewswire
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL - Stock Titan
Bionano Genomics, Inc. (NASDAQ:BNGO) Receives Average Recommendation of “Hold” from Analysts - Defense World
Is Bionano Genomics Inc. meeting your algorithmic filter criteriaSecure Trading Strategy Based on Technical Analysis - Newser
Bionano Genomics CEO to Present at Canaccord Genuity Growth Conference. - AInvest
Bionano Genomics CEO Set for Major Presentation at Canaccord's Elite Growth Conference - Stock Titan
Moving Average Trends for Bionano Genomics Inc. Stock: What They IndicateDaily Upside Movement Prediction With Data - Newser
Bionano Genomics (BNGO) Unveils Enhanced Genomic Analysis Softwa - GuruFocus
Bionano Genomics (BNGO) Unveils Enhanced Genomic Analysis Software - GuruFocus
Bionano Announces Upgrades to its Software and Compute Platforms - GuruFocus
Bionano Announces Upgrades to its Software and Compute - GlobeNewswire
Bionano's VIA 7.2 & Solve 3.8.3 enhance OGM data analysis, improve AI capabilities. - AInvest
Bionano Genomics Enhances Genomic Data Analysis with VIA 7.2 and Stratys Compute Upgrades - AInvest
Bionano's New AI Software Doubles Cancer Sample Analysis Speed, Transforms Genomic Testing Workflow - Stock Titan
Why is Bionano Genomics Inc. stock attracting strong analyst attentionDiscover market opportunities others miss - Jammu Links News
What are Bionano Genomics Inc. company’s key revenue driversExplosive wealth accumulation - Jammu Links News
Bionano Genomics 2022 Symposium - Labroots
When is Bionano Genomics Inc. stock expected to show significant growthDiscover hidden gems in the stock market - Jammu Links News
Is Bionano Genomics Inc. stock overvalued or undervaluedCapitalize on market trends before they peak - Jammu Links News
Is Bionano Genomics Inc. a good long term investmentInvest with confidence backed by data - Jammu Links News
Is it the right time to buy Bionano Genomics Inc. stockGet real-time alerts on high-potential stocks - Jammu Links News
How volatile is Bionano Genomics Inc. stock compared to the marketExceptional market positioning - Jammu Links News
Is Bionano Genomics Inc. a growth stock or a value stockRapid-fire capital growth - Jammu Links News
What drives Bionano Genomics Inc. stock priceDiscover market opportunities with real-time data - Jammu Links News
What are analysts’ price targets for Bionano Genomics Inc. in the next 12 monthsMaximize returns with strategic stock selection - Jammu Links News
What institutional investors are buying Bionano Genomics Inc. stockInvest smarter with cutting-edge analytics - Jammu Links News
Bionano Genomics to Report Q2 2025 Earnings on August 14, 2025 - AInvest
Does Bionano Genomics Inc. stock perform well during market downturnsDaily Trading Signals That Work - jammulinksnews.com
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 - The Manila Times
Bionano Genomics Demonstrates OGM Technology Momentum at European Cytogenomics Association Conference - AInvest
Understanding Bionano Genomics Inc.’s price movementWeekly Watchlist of High Movers Released - metal.it
Bionano Genomics showcases Optical Genome Mapping at European Cytogenomics Conference. - AInvest
Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium | BNGO Stock News - GuruFocus
Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium - The Manila Times
Bionano Genomics Inc. Recovery Linked to Earnings SurpriseCommunity Verified Stock Suggestions Drive Volume - metal.it
Optical Genome Mapping Studies Surge 78% at European Genetics Conference | BNGO Stock News - Stock Titan
Chart based exit strategy for Bionano Genomics Inc.Low Risk Buy Zone Opportunity Watch Ongoing - metal.it
Investors Continue Waiting On Sidelines For Bionano Genomics, Inc. (NASDAQ:BNGO) - simplywall.st
Why Bionano Genomics Inc. stock attracts strong analyst attentionInvestment Plan With Growth Optimization Finalized - beatles.ru
Is Now a Good Time to Reenter Bionano Genomics Inc.Weekly Growth Stock Entry Point Alerts Highlighted - metal.it
How did BNGO's revenue and expenses trend in Q4 2024? - AInvest
Intraday Charts Show Spike in Bionano Genomics Inc. ActivityEarnings Play Trade Plan With Alerts Shared - metal.it
What is the risk reward ratio of investing in Bionano Genomics Inc. stockExpert Picks Report For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Bionano Genomics Inc.Stock Market Entry Points To Watch Now - Jammu Links News
What makes Bionano Genomics Inc. stock price move sharply Volatility Analysis and Entry Risk Mapping - metal.it
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):